Mechanisms of steroid impairment of growth

Ze'ev Hochberg1

  • 1Pediatric Endocrinology, Meyer Children's Hospital, Haifa, Israel. z_hochberg@rambam.health.gov.il

Hormone Research
|October 10, 2002
PubMed

Insights

Glucocorticoids (GC) negatively impact child growth by affecting bone, cartilage, and muscle. Minimizing GC dosage and employing specific treatments can mitigate these growth-retarding effects.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Growth Biology

Background:

  • Child growth is a complex process influenced by numerous factors.
  • Glucocorticoids (GC) are potent medications with widespread physiological effects.
  • GC exert significant anti-anabolic and catabolic influences on developing tissues.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms by which glucocorticoids impede child growth.
  • To identify key molecular and physiological pathways affected by GC during development.
  • To explore potential strategies for mitigating GC-induced growth retardation.

Main Methods:

  • Review of existing literature on glucocorticoid effects on growth.
  • Analysis of GC interactions with the growth hormone-insulin-like growth factor 1 (GH-IGF-1) axis.
  • Examination of GC impact on bone, cartilage, muscle, and calcium homeostasis.

Main Results:

  • GC interfere with the GH-IGF-1 axis at multiple levels, including hormone release and signaling.
  • GC suppress chondrocyte proliferation, matrix synthesis, and mineralization in the growth plate.
  • GC disrupt calcium balance and negatively affect osteoblast and osteoclast function, alongside muscle strength.

Conclusions:

  • GC significantly impair child growth through direct and indirect mechanisms affecting hormonal axes and tissue development.
  • Growth damage from GC is most pronounced early in treatment, emphasizing the importance of preventive strategies.
  • Reducing GC dosage, utilizing alternative-day regimens, and considering specific analogs or growth factors may mitigate adverse effects.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...